10-Q Filing

APPLIED BIOSCIENCES CORP. CIK: 1607549 Q2 2020

Filing Information

Form Type	10-Q
Accession Number	`0001477932-19-006510`
Period End Date	20190930
Filing Date	20191114
Fiscal Year	2020
Fiscal Period	Q2
XBRL Instance	appb-20190930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 84 Income Statement 76 Cash Flow Statement 54 Stockholders Equity 36

Balance Sheet 84 line items

Line Item	Tag	Value	Unit	Period
Related party net of debt discount	`RelatedPartyNetOfDebtDiscount`	-	USD	Point-in-time
Related party net of debt discount	`RelatedPartyNetOfDebtDiscount`	$3.56K	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$73.41K	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$47.04K	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$60.93K	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$6.92K	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$163.41K	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$65.82K	USD	Point-in-time
Unrelated parties net of debt discount	`UnrelatedPartiesNetOfDebtDiscount`	-	USD	Point-in-time
Unrelated parties net of debt discount	`UnrelatedPartiesNetOfDebtDiscount`	$222.00K	USD	Point-in-time
Inventory	`InventoryNet`	$78.74K	USD	Point-in-time
Inventory	`InventoryNet`	$105.67K	USD	Point-in-time
Prepaids and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$17.00K	USD	Point-in-time
Preferred stock, shares par value	`PreferredStockParOrStatedValuePerShare`	-	USD	Point-in-time
Preferred stock, shares par value	`PreferredStockParOrStatedValuePerShare`	-	USD	Point-in-time
Prepaids and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$65.27K	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Total Current Assets	`AssetsCurrent`	$354.46K	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$261.90K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentOtherNet`	$372.55K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentOtherNet`	$452.05K	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Equity investments	`EquityMethodInvestments`	$898.29K	USD	Point-in-time
Equity investments	`EquityMethodInvestments`	$898.29K	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Goodwill (provisional)	`Goodwill`	$1.94M	USD	Point-in-time
Goodwill (provisional)	`Goodwill`	$1.94M	USD	Point-in-time
Common stock, shares par value	`CommonStockParOrStatedValuePerShare`	-	USD	Point-in-time
Common stock, shares par value	`CommonStockParOrStatedValuePerShare`	-	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Other asset	`OtherAssetsNoncurrent`	$5.50K	USD	Point-in-time
Other asset	`OtherAssetsNoncurrent`	$10.13K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	13.40M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	13.55M	shares	Point-in-time
TOTAL ASSETS	`Assets`	$3.48M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$3.65M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	13.55M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	13.40M	shares	Point-in-time
Common stock shares to be issued	`CommonStockSharesToBeIssued`	512,651.00	shares	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$325.18K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$278.55K	USD	Point-in-time
Common stock shares to be issued	`CommonStockSharesToBeIssued`	408,805.00	shares	Point-in-time
Note Payable	`NotesPayableCurrent`	$25.00K	USD	Point-in-time
Note Payable	`NotesPayableCurrent`	$25.00K	USD	Point-in-time
Convertible note payable - related party, net of debt discount of $3,565 at September 30, 2019	`ConvertibleNotePayableRelatedPartyNetOfDebtDiscountOf3565AtSeptember302019`	$188.44K	USD	Point-in-time
Convertible note payable - related party, net of debt discount of $3,565 at September 30, 2019	`ConvertibleNotePayableRelatedPartyNetOfDebtDiscountOf3565AtSeptember302019`	-	USD	Point-in-time
Convertible notes payable - unrelated parties, net of debt discount of $222,001 at September 30, 2019	`ConvertibleNotesPayableCurrent`	$277.94K	USD	Point-in-time
Convertible notes payable - unrelated parties, net of debt discount of $222,001 at September 30, 2019	`ConvertibleNotesPayableCurrent`	-	USD	Point-in-time
Derivative liability	`DerivativeLiabilities`	$194.83K	USD	Point-in-time
Derivative liability	`DerivativeLiabilities`	-	USD	Point-in-time
Accrued expenses	`OtherAccruedLiabilitiesCurrent`	$70.72K	USD	Point-in-time
Accrued expenses	`OtherAccruedLiabilitiesCurrent`	$311.25K	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$374.27K	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$1.32M	USD	Point-in-time
Commitments and Contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock; $0.00001 par value; 5,000,000 shares authorized; none issued and outstanding at September 30, 2019 (unaudited) and 2018 and March 31, 2019, respectively	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock; $0.00001 par value; 5,000,000 shares authorized; none issued and outstanding at September 30, 2019 (unaudited) and 2018 and March 31, 2019, respectively	`PreferredStockValue`	-	USD	Point-in-time
Common stock; $0.00001 par value; 200,000,000 shares authorized: 13,547,110 issued and outstanding at September 30, 2019 (unaudited) and 13,397,110 at March 31, 2019	`CommonStockValue`	$135.00	USD	Point-in-time
Common stock; $0.00001 par value; 200,000,000 shares authorized: 13,547,110 issued and outstanding at September 30, 2019 (unaudited) and 13,397,110 at March 31, 2019	`CommonStockValue`	$137.00	USD	Point-in-time
Stock subscription receivable	`TemporaryEquitySharesSubscribedButUnissuedSubscriptionsReceivable`	-	USD	Point-in-time
Stock subscription receivable	`TemporaryEquitySharesSubscribedButUnissuedSubscriptionsReceivable`	-	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$7.09M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$6.89M	USD	Point-in-time
Common stock to be issued, 512,651 shares at September 30, 2019 (unaudited) and 408,805 shares at March 31, 2019	`CommonStockCapitalSharesReservedForFutureIssuance`	823,807.00	shares	Point-in-time
Common stock to be issued, 512,651 shares at September 30, 2019 (unaudited) and 408,805 shares at March 31, 2019	`CommonStockCapitalSharesReservedForFutureIssuance`	773,807.00	shares	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-5.53M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-6.73M	USD	Point-in-time
Total Applied BioSciences Corp. Stockholders' Equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$2.13M	USD	Point-in-time
Total Applied BioSciences Corp. Stockholders' Equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.18M	USD	Point-in-time
Non-controlling deficit	`NoncontrollingInterestInVariableInterestEntity`	$1.14M	USD	Point-in-time
Non-controlling deficit	`NoncontrollingInterestInVariableInterestEntity`	$980.74K	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$648.32K	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$650.38K	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$669.44K	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$3.28M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$2.16M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$2.85M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$3.48M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$3.65M	USD	Point-in-time

Income Statement 76 line items

Line Item	Tag	Value	Unit	Period
Products	`Products`	$83.91K	USD	1 Quarter
Products	`Products`	$48.97K	USD	1 Quarter
Products	`Products`	$169.65K	USD	2 Qtrs
Products	`Products`	$59.40K	USD	2 Qtrs
Services	`Services`	$286.08K	USD	2 Qtrs
Services	`Services`	$160.36K	USD	1 Quarter
Services	`Services`	-	USD	1 Quarter
Services	`Services`	-	USD	2 Qtrs
Total revenues, net	`Revenues`	$244.27K	USD	1 Quarter
Total revenues, net	`Revenues`	$48.97K	USD	1 Quarter
Total revenues, net	`Revenues`	$455.73K	USD	2 Qtrs
Total revenues, net	`Revenues`	$59.40K	USD	2 Qtrs
Total costs of revenue	`CostOfRevenue`	$198.17K	USD	2 Qtrs
Total costs of revenue	`CostOfRevenue`	$60.16K	USD	2 Qtrs
Total costs of revenue	`CostOfRevenue`	$42.40K	USD	1 Quarter
Total costs of revenue	`CostOfRevenue`	$98.37K	USD	1 Quarter
GROSS MARGIN (LOSS)	`GrossProfit`	$-758.00	USD	2 Qtrs
GROSS MARGIN (LOSS)	`GrossProfit`	$257.56K	USD	2 Qtrs
GROSS MARGIN (LOSS)	`GrossProfit`	$6.57K	USD	1 Quarter
GROSS MARGIN (LOSS)	`GrossProfit`	$145.90K	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	$329.44K	USD	2 Qtrs
Sales and marketing	`SellingAndMarketingExpense`	$219.81K	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	$455.44K	USD	2 Qtrs
Sales and marketing	`SellingAndMarketingExpense`	$111.39K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$188.05K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$707.19K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$1.15M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$395.20K	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$292.00	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$79.50K	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$39.75K	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$585.00	USD	2 Qtrs
TOTAL OPERATING EXPENSES	`OperatingExpenses`	$299.74K	USD	1 Quarter
TOTAL OPERATING EXPENSES	`OperatingExpenses`	$966.75K	USD	1 Quarter
TOTAL OPERATING EXPENSES	`OperatingExpenses`	$851.22K	USD	2 Qtrs
TOTAL OPERATING EXPENSES	`OperatingExpenses`	$1.56M	USD	2 Qtrs
OPERATING LOSS	`OperatingIncomeLoss`	$-851.98K	USD	2 Qtrs
OPERATING LOSS	`OperatingIncomeLoss`	$-1.30M	USD	2 Qtrs
OPERATING LOSS	`OperatingIncomeLoss`	$-820.85K	USD	1 Quarter
OPERATING LOSS	`OperatingIncomeLoss`	$-293.17K	USD	1 Quarter
Unrealized gain on equity investments	`UnrealizedGainLossOnInvestments`	-	USD	1 Quarter
Unrealized gain on equity investments	`UnrealizedGainLossOnInvestments`	$404.76K	USD	2 Qtrs
Unrealized gain on equity investments	`UnrealizedGainLossOnInvestments`	-	USD	2 Qtrs
Unrealized gain on equity investments	`UnrealizedGainLossOnInvestments`	$245.83K	USD	1 Quarter
Change in fair value of derivative	`DerivativeGainLossOnDerivativeNet`	-	USD	1 Quarter
Change in fair value of derivative	`DerivativeGainLossOnDerivativeNet`	$4.25K	USD	1 Quarter
Change in fair value of derivative	`DerivativeGainLossOnDerivativeNet`	-	USD	2 Qtrs
Change in fair value of derivative	`DerivativeGainLossOnDerivativeNet`	$4.25K	USD	2 Qtrs
Interest Expense	`InterestExpense`	$-64.80K	USD	2 Qtrs
Interest Expense	`InterestExpense`	$-38.64K	USD	1 Quarter
Interest Expense	`InterestExpense`	$-68.30K	USD	2 Qtrs
Interest Expense	`InterestExpense`	$-66.42K	USD	1 Quarter
Total other (expense), net	`OtherNonoperatingIncomeExpense`	$179.41K	USD	1 Quarter
Total other (expense), net	`OtherNonoperatingIncomeExpense`	$-34.38K	USD	1 Quarter
Total other (expense), net	`OtherNonoperatingIncomeExpense`	$-60.55K	USD	2 Qtrs
Total other (expense), net	`OtherNonoperatingIncomeExpense`	$336.46K	USD	2 Qtrs
NET LOSS	`NetIncomeLoss`	$-1.36M	USD	2 Qtrs
NET LOSS	`NetIncomeLoss`	$-855.23K	USD	1 Quarter
NET LOSS	`NetIncomeLoss`	$-515.52K	USD	2 Qtrs
NET LOSS	`NetIncomeLoss`	$-113.76K	USD	1 Quarter
Less: Net loss attributable to non controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$3.34K	USD	1 Quarter
Less: Net loss attributable to non controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$9.59K	USD	2 Qtrs
Less: Net loss attributable to non controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$161.51K	USD	2 Qtrs
Less: Net loss attributable to non controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$77.48K	USD	1 Quarter
NET LOSS ATTRIBUTABLE TO APPLIED BIOSCIENCES CORP.	`IncomeLossAttributableToParent`	$-505.92K	USD	2 Qtrs
NET LOSS ATTRIBUTABLE TO APPLIED BIOSCIENCES CORP.	`IncomeLossAttributableToParent`	$-1.20M	USD	2 Qtrs
NET LOSS ATTRIBUTABLE TO APPLIED BIOSCIENCES CORP.	`IncomeLossAttributableToParent`	$-110.42K	USD	1 Quarter
NET LOSS ATTRIBUTABLE TO APPLIED BIOSCIENCES CORP.	`IncomeLossAttributableToParent`	$-777.75K	USD	1 Quarter
LOSS PER COMMON SHARE	`EarningsPerShareBasicAndDiluted`	$-0.06	USD	1 Quarter
LOSS PER COMMON SHARE	`EarningsPerShareBasicAndDiluted`	$-0.05	USD	2 Qtrs
LOSS PER COMMON SHARE	`EarningsPerShareBasicAndDiluted`	$-0.01	USD	1 Quarter
LOSS PER COMMON SHARE	`EarningsPerShareBasicAndDiluted`	$-0.09	USD	2 Qtrs
Basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	13.47M	shares	1 Quarter
Basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	13.46M	shares	2 Qtrs
Basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	10.62M	shares	2 Qtrs
Basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	10.68M	shares	1 Quarter

Cash Flow Statement 54 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-1.36M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-855.23K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-515.52K	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-113.76K	USD	1 Quarter
Unrecognized gain on equity investments	`UnrecognizedGainOnEquityInvestments`	$-404.76K	USD	2 Qtrs
Unrecognized gain on equity investments	`UnrecognizedGainOnEquityInvestments`	-	USD	2 Qtrs
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$42.72K	USD	2 Qtrs
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$50.90K	USD	2 Qtrs
Change in fair value of derivative	`DerivativeGainLossOnDerivativeNet`	-	USD	1 Quarter
Change in fair value of derivative	`DerivativeGainLossOnDerivativeNet`	$4.25K	USD	1 Quarter
Change in fair value of derivative	`DerivativeGainLossOnDerivativeNet`	-	USD	2 Qtrs
Change in fair value of derivative	`DerivativeGainLossOnDerivativeNet`	$4.25K	USD	2 Qtrs
Fair value of shares issued to consultants	`FairValueOfSharesIssuedToConsultants`	-	USD	2 Qtrs
Fair value of shares issued to consultants	`FairValueOfSharesIssuedToConsultants`	$255.35K	USD	2 Qtrs
Fair value of shares issued to officers and board member	`StockIssuedDuringPeriodValueOther`	-	USD	2 Qtrs
Fair value of shares issued to officers and board member	`StockIssuedDuringPeriodValueOther`	$70.00K	USD	2 Qtrs
Depreciation	`Depreciation`	$79.50K	USD	2 Qtrs
Depreciation	`Depreciation`	$586.00	USD	2 Qtrs
Allowance for bad debt	`AllowanceForBadDebt`	-	USD	2 Qtrs
Allowance for bad debt	`AllowanceForBadDebt`	$31.75K	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$65.83K	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$1.32K	USD	2 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$-26.93K	USD	2 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$-22.60K	USD	2 Qtrs
Prepaid and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$43.64K	USD	2 Qtrs
Prepaid and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$107.50K	USD	2 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$241.89K	USD	2 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$287.16K	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-293.51K	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-765.57K	USD	2 Qtrs
Proceeds from issuance of convertible notes	`ProceedsFromIssuanceOfConvertibleNotes`	$791.94K	USD	2 Qtrs
Proceeds from issuance of convertible notes	`ProceedsFromIssuanceOfConvertibleNotes`	$164.50K	USD	2 Qtrs
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	-	USD	2 Qtrs
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$75.00K	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$239.50K	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$791.94K	USD	2 Qtrs
NET CHANGE IN CASH	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$26.37K	USD	2 Qtrs
NET CHANGE IN CASH	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-54.01K	USD	2 Qtrs
CASH, BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$73.41K	USD	Point-in-time
CASH, BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$47.04K	USD	Point-in-time
CASH, BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$60.93K	USD	Point-in-time
CASH, BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$6.92K	USD	Point-in-time
CASH, END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$73.41K	USD	Point-in-time
CASH, END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$47.04K	USD	Point-in-time
CASH, END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$60.93K	USD	Point-in-time
CASH, END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$6.92K	USD	Point-in-time
Fair value of shares issued to consultants recorded as prepaid	`FairValueOfSharesIssuedToConsultantsRecordedAsPrepaid`	-	USD	2 Qtrs
Fair value of shares issued to consultants recorded as prepaid	`FairValueOfSharesIssuedToConsultantsRecordedAsPrepaid`	$37.50K	USD	2 Qtrs
Fair value of beneficial conversion feature related to issuance of convertible notes	`FairValueOfBeneficialConversionFeatureRelatedToIssuanceOfConvertibleNotes`	$128.60K	USD	2 Qtrs
Fair value of beneficial conversion feature related to issuance of convertible notes	`FairValueOfBeneficialConversionFeatureRelatedToIssuanceOfConvertibleNotes`	$77.38K	USD	2 Qtrs
Fair value of conversion feature recorded as a derivative liability	`FairValueOfConversionFeatureRecordedAsADerivativeLiability`	$199.08K	USD	2 Qtrs
Fair value of conversion feature recorded as a derivative liability	`FairValueOfConversionFeatureRecordedAsADerivativeLiability`	-	USD	2 Qtrs
Common stock to be issued upon conversion of note	`CommonStockToBeIssuedUponConversionOfNote`	-	USD	2 Qtrs
Common stock to be issued upon conversion of note	`CommonStockToBeIssuedUponConversionOfNote`	$100.00K	USD	2 Qtrs

Stockholders Equity 36 line items

Line Item	Tag	Value	Unit	Period
Balance, shares	`SharesIssued`	-	shares	Point-in-time
Balance, shares	`SharesIssued`	-	shares	Point-in-time
Balance, shares	`SharesIssued`	-	shares	Point-in-time
Balance, shares	`SharesIssued`	-	shares	Point-in-time
Balance, shares	`SharesIssued`	-	shares	Point-in-time
Balance, shares	`SharesIssued`	-	shares	Point-in-time
Balance, amount	`StockholdersEquity`	$648.32K	USD	Point-in-time
Balance, amount	`StockholdersEquity`	$650.38K	USD	Point-in-time
Balance, amount	`StockholdersEquity`	$669.44K	USD	Point-in-time
Balance, amount	`StockholdersEquity`	$3.28M	USD	Point-in-time
Balance, amount	`StockholdersEquity`	$2.16M	USD	Point-in-time
Balance, amount	`StockholdersEquity`	$2.85M	USD	Point-in-time
Net Income (Loss)	`ProfitLoss`	$-855.23K	USD	1 Quarter
Net Income (Loss)	`ProfitLoss`	$-507.93K	USD	1 Quarter
Net Income (Loss)	`ProfitLoss`	$-113.76K	USD	1 Quarter
Net Income (Loss)	`ProfitLoss`	$-401.76K	USD	1 Quarter
Fair value of common stock issued to former board member, amount	`FairValueOfCommonStockIssuedToFormerBoardMemberAmount`	$70.00K	USD	1 Quarter
Fair value of shares issued to consultant for services, amount	`FairValueOfSharesIssuedToConsultantForServicesAmount`	$15.93K	USD	1 Quarter
Fair value of shares issued to consultant for services, amount	`FairValueOfSharesIssuedToConsultantForServicesAmount`	$225.93K	USD	1 Quarter
Fair value of shares issued to advisory board member, amount	`FairValueOfSharesIssuedToAdvisoryBoardMemberAmount`	$51.00K	USD	1 Quarter
Beneficial conversion feature associated with a convertible note	`DebtInstrumentConvertibleBeneficialConversionFeature`	$28.70K	USD	1 Quarter
Beneficial conversion feature associated with a convertible note	`DebtInstrumentConvertibleBeneficialConversionFeature`	$77.38K	USD	1 Quarter
Beneficial conversion feature associated with a convertible note	`DebtInstrumentConvertibleBeneficialConversionFeature`	$100.00K	USD	1 Quarter
Beneficial conversion feature associated with a convertible note	`DebtInstrumentConvertibleBeneficialConversionFeature`	$99.90K	USD	1 Quarter
Balance, shares	`SharesIssued`	-	shares	Point-in-time
Balance, shares	`SharesIssued`	-	shares	Point-in-time
Balance, shares	`SharesIssued`	-	shares	Point-in-time
Balance, shares	`SharesIssued`	-	shares	Point-in-time
Balance, shares	`SharesIssued`	-	shares	Point-in-time
Balance, shares	`SharesIssued`	-	shares	Point-in-time
Balance, amount	`StockholdersEquity`	$648.32K	USD	Point-in-time
Balance, amount	`StockholdersEquity`	$650.38K	USD	Point-in-time
Balance, amount	`StockholdersEquity`	$669.44K	USD	Point-in-time
Balance, amount	`StockholdersEquity`	$3.28M	USD	Point-in-time
Balance, amount	`StockholdersEquity`	$2.16M	USD	Point-in-time
Balance, amount	`StockholdersEquity`	$2.85M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.